Back to search

Article

Evaluation of diversity levels of the integrase gene sequences coming from HIV-1 virus, supporting the lack of target specificity of ivermectin <i>versus</i> the integrase-importin complex in SARS-CoV-2 infection

2020-07-20

Abstract excerpt

Therapies with new drugs have been appearing in tests worldwide as potential inhibitors of sars-cov-2 virus replication. Recently, one of these drugs, Ivermectin, was reported as an inhibitor of the nuclear import of HIV-1 proteins in vitro , soon becoming the target of an international prospecting work (not yet published), with patients tested for COVID-19. However, understanding the evolutionary aspects of the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2875b2cd-b60f-528f-bc89-9657f3a9b362
DOI
10.1101/2020.07.18.210096
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluation of diversity levels of the integrase gene sequences coming from HIV-1 virus, supporting the lack of target specificity of ivermectin <i>versus</i> the integrase-importin complex in SARS-CoV-2 infectionDOI 10.1101/2020.07.18.210096
Select a neighboring publication to make it the new centre.